We have previously shown that treatment of Alzheimer’s Disease (AD) model mice with iododiflunisal (IDIF), a TTR tetramer stabilizing compound, prevents AD pathologies. Here, TTR is linked to early-onset autosomal dominant Alzheimer disease.